Research Proposal Submissions

The Angelman Syndrome Foundation accepts research proposals on a continual basis, with submission deadlines for subsequent review occurring on August 15.

One- or two-year grants are awarded for various amounts of up to $100,000 per year.

Instructions for Submission

All proposals, including cover letters, should be submitted in one .pdf file using the ASF Grant Submission Form.
If you experience a problem downloading the form, open this page in a different browser or an incognito window.

Questions should be directed to ASF Scientific Advisory Chair at: research@angelman.org.

1.

Name of Proposal File

The file name of the pdf should be:

PI’s last name_MM_20XX_Gen_RFP.pdf
(e.g., Smith_8_2025_Gen_RFP.pdf)

2.

Details to Include in Proposal

Cover page including title of proposal and name of principal investigator
One-page summary abstract of proposed research
Proposal, including hypothesis, background, research plan, and significance of the proposed research; page limits indicated within application
Curriculum vitae of the applicant
One-page detailed budget. Indirect costs of up to 10% will be allowed (to be included in the total budget amount not to exceed $100,000 per year)
Proposals involving human or animal subjects must be approved by institutional review boards before funding is released. Please include approval with proposal if possible.

3.

Submit Proposal Via Email

Attach your proposal to an email sent to amoore@angelman.org with the subject line to read:

ASF MM_20XX General RFP Submission
(e.g., ASF 8_2025 General RFP Submission)

Specialties

Clinical Trials

Global Health

Eligibility Requirements

Research Priorities

The ASF Scientific Advisory Committee identified the following areas of unmet need in AS research. Priority will be given to the following topics:

Projects studying or correcting the heterozygous effect of non-UBE3A genes in deletion.
Projects studying the potential results of increasing UBE3A after therapies or for some subtypes of AS.
Projects studying delivery of therapies and potential for improvement.
Symptomatic therapies that impact the daily life of people with Angelman syndrome and their families.

Proposals that do not address these topics are still welcome and will be given full consideration.

Sponsor Details

Sponsor Institute/Organizations: Angelman Syndrome Foundation

Sponsor Type: Corporate/Non-Profit

Address: 3015 E. New York Street Suite A2-#285 Aurora, IL 60504

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity